RS20050393A - Improved process for the preparation of 1,3-substituted indenes - Google Patents
Improved process for the preparation of 1,3-substituted indenesInfo
- Publication number
- RS20050393A RS20050393A YUP-2005/0393A YUP20050393A RS20050393A RS 20050393 A RS20050393 A RS 20050393A YU P20050393 A YUP20050393 A YU P20050393A RS 20050393 A RS20050393 A RS 20050393A
- Authority
- RS
- Serbia
- Prior art keywords
- preparation
- improved process
- substituted indenes
- indenes
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Circuit Arrangements For Discharge Lamps (AREA)
Abstract
Poboljšan postupak za dobijanje 1,3-supstituisaih indena, koji su korisni intermedijeri u sintezi aril kondenzovanih azapolicikličnih jedinjenja koja pokazuju aktivnost kao agensi za lečenje neuroloških i psiholoških oboljenja.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42902902P | 2002-11-25 | 2002-11-25 | |
PCT/IB2003/005121 WO2004048318A1 (en) | 2002-11-25 | 2003-11-12 | Improved process for the preparation of 1,3-substituted indenes |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20050393A true RS20050393A (en) | 2007-12-31 |
Family
ID=32393492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0393A RS20050393A (en) | 2002-11-25 | 2003-11-12 | Improved process for the preparation of 1,3-substituted indenes |
Country Status (16)
Country | Link |
---|---|
US (1) | US7285686B2 (sr) |
EP (1) | EP1567483A1 (sr) |
JP (1) | JP2006507342A (sr) |
KR (1) | KR100655848B1 (sr) |
CN (1) | CN1714075A (sr) |
AR (1) | AR042205A1 (sr) |
AU (1) | AU2003278510B8 (sr) |
BR (1) | BR0316482A (sr) |
CA (1) | CA2511762A1 (sr) |
MX (1) | MXPA05005517A (sr) |
PL (1) | PL377292A1 (sr) |
RS (1) | RS20050393A (sr) |
RU (1) | RU2284319C2 (sr) |
TW (1) | TWI245756B (sr) |
WO (1) | WO2004048318A1 (sr) |
ZA (1) | ZA200503190B (sr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1919973A1 (en) | 2005-08-11 | 2008-05-14 | University Of Massachusetts Lowell | Novel methods for forming copolymers comprising olefin and protected or unprotected hydroxystyrene units |
WO2009143347A2 (en) | 2008-05-22 | 2009-11-26 | Teva Pharmaceutical Industries Ltd. | Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
WO2009155403A2 (en) * | 2008-06-19 | 2009-12-23 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of varenicline and intermediates thereof |
US20100010221A1 (en) * | 2008-07-10 | 2010-01-14 | Revital Lifshitz-Liron | Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
RU2012102052A (ru) | 2009-06-22 | 2013-11-20 | Тева Фармасьютикал Индастриз Лтд. | Твердые формы солей варениклина и способы их получения |
WO2016164744A1 (en) * | 2015-04-08 | 2016-10-13 | Kemin Industries, Inc. | Protective action of lutein against blue light on human skin cell lines |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK286886B6 (sk) | 1997-12-31 | 2009-07-06 | Pfizer Products Inc. | Azapolycyklické zlúčeniny s anelovanou arylskupinou, ich použitie, farmaceutické kompozície na ich báze a medziprodukty |
US6605610B1 (en) | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
CZ20032814A3 (cs) * | 2001-04-20 | 2004-08-18 | Pfizeráproductsáinc | Způsob přípravy �Ź@@substituovaných indenů a aryl@kondezovaných azapolycyklických sloučenin |
DE60322416D1 (de) | 2002-11-20 | 2008-09-04 | Pfizer Prod Inc | Methode zur herstellung von indan-1,3-dicarbonsäuren |
WO2004063164A1 (en) | 2003-01-15 | 2004-07-29 | Pfizer Products Inc. | Process for the preparation of aryl fused polycyclic lactams |
-
2003
- 2003-11-12 CA CA002511762A patent/CA2511762A1/en not_active Abandoned
- 2003-11-12 MX MXPA05005517A patent/MXPA05005517A/es active IP Right Grant
- 2003-11-12 RS YUP-2005/0393A patent/RS20050393A/sr unknown
- 2003-11-12 EP EP03769810A patent/EP1567483A1/en not_active Withdrawn
- 2003-11-12 AU AU2003278510A patent/AU2003278510B8/en not_active Ceased
- 2003-11-12 KR KR1020057009301A patent/KR100655848B1/ko not_active IP Right Cessation
- 2003-11-12 JP JP2004554771A patent/JP2006507342A/ja not_active Withdrawn
- 2003-11-12 CN CNA2003801040364A patent/CN1714075A/zh active Pending
- 2003-11-12 PL PL377292A patent/PL377292A1/pl unknown
- 2003-11-12 BR BR0316482-9A patent/BR0316482A/pt not_active IP Right Cessation
- 2003-11-12 WO PCT/IB2003/005121 patent/WO2004048318A1/en active Application Filing
- 2003-11-12 RU RU2005115881/04A patent/RU2284319C2/ru active
- 2003-11-17 US US10/714,735 patent/US7285686B2/en not_active Expired - Fee Related
- 2003-11-24 AR ARP030104329A patent/AR042205A1/es unknown
- 2003-11-24 TW TW092132907A patent/TWI245756B/zh not_active IP Right Cessation
-
2005
- 2005-04-20 ZA ZA200503190A patent/ZA200503190B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003278510B8 (en) | 2008-07-10 |
US7285686B2 (en) | 2007-10-23 |
WO2004048318A1 (en) | 2004-06-10 |
TWI245756B (en) | 2005-12-21 |
ZA200503190B (en) | 2006-07-26 |
RU2005115881A (ru) | 2006-02-27 |
US20050004379A1 (en) | 2005-01-06 |
KR100655848B1 (ko) | 2006-12-11 |
CA2511762A1 (en) | 2004-06-10 |
CN1714075A (zh) | 2005-12-28 |
WO2004048318A8 (en) | 2005-05-12 |
KR20050087801A (ko) | 2005-08-31 |
EP1567483A1 (en) | 2005-08-31 |
BR0316482A (pt) | 2005-10-11 |
PL377292A1 (pl) | 2006-01-23 |
TW200413301A (en) | 2004-08-01 |
AR042205A1 (es) | 2005-06-15 |
MXPA05005517A (es) | 2005-07-25 |
JP2006507342A (ja) | 2006-03-02 |
RU2284319C2 (ru) | 2006-09-27 |
AU2003278510A1 (en) | 2004-06-18 |
AU2003278510B2 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200500344A (en) | Novel compounds | |
MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
TW200407305A (en) | Novel compounds | |
SI1474416T1 (sl) | Derivati dihidrobenzodiazepin-2-ona za zdravljenje nevroloskih motenj | |
BG104561A (en) | Aryl fused azapolycyclic compounds | |
IL157491A0 (en) | Heteropolycyclic compounds and pharmaceutical compositions containing the same | |
AU2003249983A8 (en) | Piperidines useful for the treatment of central nervous system disorders | |
SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
MY131442A (en) | Excitatory amino acid receptor antagonists | |
MXPA04001940A (es) | Tratamiento para desordenes del sistema nervioso central. | |
TW200510303A (en) | Novel compounds | |
TW200504034A (en) | Therapeutic agents | |
TW200503710A (en) | Novel compounds | |
MX2007006754A (es) | Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos. | |
MY124786A (en) | Bis-arylsulfones | |
TW200514781A (en) | Novel compounds | |
DE60304695D1 (de) | 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN | |
TW200509933A (en) | Therapeutic agents | |
MY133474A (en) | Aryl fused azapolycyclic compounds | |
TWI245756B (en) | Improved process for the preparation of 1,3-substituted indenes | |
MXPA02001204A (es) | Compuestos calciliticos. | |
ATE256126T1 (de) | 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen | |
TW200420286A (en) | Improved process for the preparation of aryl fused polycyclic lactams | |
WO2004046077A8 (en) | A method for preparing indan-1,3-dicarboxylic acid | |
AU2003202255A8 (en) | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same |